Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381276507> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W4381276507 endingPage "187" @default.
- W4381276507 startingPage "182" @default.
- W4381276507 abstract "Acute respiratory viral infection is one of the most common infectious diseases. Clinical manifestations vary from time to time and from person to person and, as a rule, include intoxication and catarrhal syndromes. ARVI is more often caused by such causative agents as pneumoviruses, human metapneumovirus, coronaviruses, rhinoviruses, adenoviruses and bocaviruses. Among diseases of the ENT organs, ARVI can cause rhinosinusitis and pharyngitis. The inflammation that occurs in the mucosa causes its dystrophy and necrosis, which leads to the dysfunction of mucociliary clearance. As a result, an optimal environment for the development of bacterial flora is created. Bacterial rhinosinusitis needs antibiotic therapy. These drugs can act locally and systemically. It is well known that topical drugs have fewer side effects and result in a greater active substance concentration directly at a site of inflammation. Currently, a nasal framycetin spray is used as a topical antibacterial therapy to treat bacterial rhinosinusitis and in the early postoperative period. Topical drugs have a good evidence base, fewer side effects, and are safe, even for patients with cystic fibrosis. Given the significant antibiotics load in patients with cystic fibrosis, any opportunity to delay re-administration of antibiotics is a positive thing. In this aspect, topical antibiotics that have no systemic adverse events, including negative effects on the normal human microbiome, and can be used to overcome the resistance of microorganisms in a varying degree due to the achievement of high active substance concentration directly in a focus of infection may have a certain therapeutic value. The article addresses issues of epidemiology, pathogenesis, clinical manifestations of acute respiratory viral infection, i. e. acute rhinosinusitis. In addition, the article describes the use of topical antibiotic therapy for the treatment of diseases of the nasal cavities and paranasal sinuses." @default.
- W4381276507 created "2023-06-20" @default.
- W4381276507 creator A5007684130 @default.
- W4381276507 creator A5066740937 @default.
- W4381276507 creator A5087360974 @default.
- W4381276507 date "2023-05-11" @default.
- W4381276507 modified "2023-09-23" @default.
- W4381276507 title "Local antibacterial therapy in patients with diseases of the nasal cavity and paranasal sinuses, including against the background of cystic fibrosis" @default.
- W4381276507 cites W2021359366 @default.
- W4381276507 cites W2289016262 @default.
- W4381276507 cites W2530582549 @default.
- W4381276507 cites W2807882205 @default.
- W4381276507 cites W3013681400 @default.
- W4381276507 cites W3029243269 @default.
- W4381276507 cites W3197006061 @default.
- W4381276507 doi "https://doi.org/10.21518/ms2022-053" @default.
- W4381276507 hasPublicationYear "2023" @default.
- W4381276507 type Work @default.
- W4381276507 citedByCount "0" @default.
- W4381276507 crossrefType "journal-article" @default.
- W4381276507 hasAuthorship W4381276507A5007684130 @default.
- W4381276507 hasAuthorship W4381276507A5066740937 @default.
- W4381276507 hasAuthorship W4381276507A5087360974 @default.
- W4381276507 hasBestOaLocation W43812765071 @default.
- W4381276507 hasConcept C114682108 @default.
- W4381276507 hasConcept C126322002 @default.
- W4381276507 hasConcept C141071460 @default.
- W4381276507 hasConcept C142724271 @default.
- W4381276507 hasConcept C197934379 @default.
- W4381276507 hasConcept C203014093 @default.
- W4381276507 hasConcept C2776938444 @default.
- W4381276507 hasConcept C2777714996 @default.
- W4381276507 hasConcept C2777768476 @default.
- W4381276507 hasConcept C2777955602 @default.
- W4381276507 hasConcept C2778801703 @default.
- W4381276507 hasConcept C501593827 @default.
- W4381276507 hasConcept C71924100 @default.
- W4381276507 hasConcept C86803240 @default.
- W4381276507 hasConcept C89423630 @default.
- W4381276507 hasConceptScore W4381276507C114682108 @default.
- W4381276507 hasConceptScore W4381276507C126322002 @default.
- W4381276507 hasConceptScore W4381276507C141071460 @default.
- W4381276507 hasConceptScore W4381276507C142724271 @default.
- W4381276507 hasConceptScore W4381276507C197934379 @default.
- W4381276507 hasConceptScore W4381276507C203014093 @default.
- W4381276507 hasConceptScore W4381276507C2776938444 @default.
- W4381276507 hasConceptScore W4381276507C2777714996 @default.
- W4381276507 hasConceptScore W4381276507C2777768476 @default.
- W4381276507 hasConceptScore W4381276507C2777955602 @default.
- W4381276507 hasConceptScore W4381276507C2778801703 @default.
- W4381276507 hasConceptScore W4381276507C501593827 @default.
- W4381276507 hasConceptScore W4381276507C71924100 @default.
- W4381276507 hasConceptScore W4381276507C86803240 @default.
- W4381276507 hasConceptScore W4381276507C89423630 @default.
- W4381276507 hasIssue "7" @default.
- W4381276507 hasLocation W43812765071 @default.
- W4381276507 hasOpenAccess W4381276507 @default.
- W4381276507 hasPrimaryLocation W43812765071 @default.
- W4381276507 hasRelatedWork W1974274072 @default.
- W4381276507 hasRelatedWork W1985025364 @default.
- W4381276507 hasRelatedWork W2094367506 @default.
- W4381276507 hasRelatedWork W2122980249 @default.
- W4381276507 hasRelatedWork W2299384619 @default.
- W4381276507 hasRelatedWork W2401773602 @default.
- W4381276507 hasRelatedWork W2498998636 @default.
- W4381276507 hasRelatedWork W2549577280 @default.
- W4381276507 hasRelatedWork W3081624231 @default.
- W4381276507 hasRelatedWork W4297981766 @default.
- W4381276507 isParatext "false" @default.
- W4381276507 isRetracted "false" @default.
- W4381276507 workType "article" @default.